ß2-integrins as regulators of dendritic cell metabolism and dendritic cell-induced anti-tumor responses
Description of the granted funding
Dendritic cells (DCs) are a type of white blood cells which are of fundamental importance in initiating immune responses, and immunotherapy utilizing these cells, give hope to cure cancer. However, the clinical efficacy of DC vaccines have yet been debatable, and improving the functionality of DCs in patients is clearly required. Integrins are cell surface molecules that play various important roles in the immune system. We are interested in one particular group of integrins which has been shown to negatively regulate DC function. We aim to study the mechanism which is used by these integrins to suppress DC function and then to inhibit this mechanism in order to activate the immune system to fight cancer. We will use mouse DCs and various mouse tumor models to study this. The reseach will take place at the Viikki campus of the University of Helsinki. More information about our research can be found from our website: https://www.helsinki.fi/en/researchgroups/integrins-in-immunity.
Show moreStarting year
2021
End year
2025
Granted funding
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Other information
Funding decision number
342995
Fields of science
Biochemistry, cell and molecular biology
Research fields
Solu- ja molekyylibiologia
Identified topics
cancer